- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rebif New Formulation Non Titrated
Total 469 results
-
EMD SeronoCompletedRelapsing Multiple SclerosisUnited States
-
GenfitNaturalpha; SGS Aster S.A.S.CompletedCardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | ObeseFrance
-
Merck KGaA, Darmstadt, GermanyCompleted
-
EMD SeronoCompleted12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.Multiple SclerosisUnited States, Canada, Germany, Italy, Spain, Sweden
-
Merck KGaA, Darmstadt, GermanyMerck Serono Australia Pty LtdCompleted
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisLebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
-
GlaxoSmithKlineCompletedSubstance DependenceUnited Kingdom
-
The Netherlands Cancer InstituteCompleted
-
TakedaCompleted
-
GlaxoSmithKlineCompleted
-
ESM Technologies, LLCCompletedOsteoarthritis | FibromyalgiaUnited States
-
Boehringer IngelheimTerminated
-
TakedaCompletedHypothyroidismBelgium
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Derming SRLCompletedTelogen Effluvium
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
Embera NeuroTherapeutics, Inc.National Institute on Drug Abuse (NIDA)CompletedCocaine Use DisorderUnited States
-
AbbVie (prior sponsor, Abbott)CompletedRheumatoid ArthritisUnited States, Belgium, Czech Republic, Germany, Puerto Rico, Romania, Slovakia
-
Boehringer IngelheimCompleted
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
TaiGen Biotechnology Co., Ltd.Completed
-
Boehringer IngelheimCompleted
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineActive, not recruitingHerpes SimplexGermany, United States, Belgium, Canada, Spain, United Kingdom, Estonia, Australia
-
Boehringer IngelheimCompleted
-
University Hospital, GrenobleCompleted
-
GlaxoSmithKlineCompletedHypertension, PulmonaryUnited Kingdom
-
AmgenCompletedArthritis, Rheumatoid; Arthritis, PsoriaticUnited States, Puerto Rico
-
University Hospital, GrenobleCompleted
-
AstraZenecaCompletedParkinson's DiseaseUnited Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedRheumatoid ArthritisUnited States, Belgium, Czech Republic, Germany, Puerto Rico, Romania, Slovakia
-
AllerganCompletedDry Eye SyndromesCanada, Australia
-
QualiLife PharmaceuticalsCompleted
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
GlaxoSmithKlineCompletedMeasles | Rubella | Mumps | VaricellaTaiwan, Singapore
-
Boehringer IngelheimCompleted
-
Dr. Ekong E. UdohUnknownMalnutrition; ModerateNigeria
-
Alcon ResearchCompletedOcular Hypertension | Glaucoma
-
Centre Hospitalier Universitaire de NiceRecruitingFacioscapulohumeral Muscular DystrophyFrance
-
SanofiCompleted
-
Merck KGaA, Darmstadt, GermanyEMD Serono Canada Inc.CompletedClinically Isolated SyndromeCanada
-
Alcon ResearchWithdrawnOcular Hypertension | Open Angle Glaucoma
-
Dr David DE BELSRecruiting
-
Norwegian University of Science and TechnologyCompleted
-
Meir Medical CenterUnknownAdmission to the NICU and Need for Physiological Monitoring.Israel